
出品单位: | 中投顾问的专业实力? |
最新修订: | March 2009 定制报告 |
报告页数: | 124页 字数:0万字 图表:0个 |
优惠价格: | 印刷版 + 电子版:RMB 7800 |
原价: | RMB 9800 |
订购热线: | 0755 - 82571522 82571566 400 008 1522 |
值班电话: | 13802708576 (周一至周六18:00以后,周日及法定节假日全天) |
- 报告目录
- 内容简介
- 图表目录
1.EXECUTIVESUMMARY
Overview
·OverviewoftheHeadandNeckCancerTherapeuticsMarket
2.GLOSSARYOFTERMS
ListofTerms
·Abbreviations
3.MARKETOVERVIEW
Introduction
·DiseaseCharacteristics
·Epidemiology
MarketDefinitionandSegmentation
·Definition
·Segmentation
4.RESEARCHMETHODOLOGY
ResearchObjectivesandScope
·Methodology
·AssumptionsandLimitations
5.INDUSTRYCHALLENGES
IndustryChallengesfortheEuropeanHeadandNeckCancerTherapeuticsMarkets
·ChallengesFacedbyPharmaceuticalCompanies
6.TOTALEUROPEANHEADANDNECKCANCERTHERAPEUTICSMARKET
OverviewandDefinitions
·Introduction
·MarketDrivers
·MarketRestraints
·CurrentTherapeuticOptions
·FutureTherapeuticApproaches
·CurrentTreatmentGuidelines
·PricingTrends
·MarketEngineeringMeasurementAnalysis
CompetitiveAnalysis
·ProfilesofKeyIndustryParticipantsandMarketShareAnalysis
·PipelineAnalysis
7.TOTALFORECASTSFORTHEEUROPEANHEADANDNECKCANCERTHERAPEUTICSMARKET
Forecasts
·PatientForecasts
·MarketRevenueForecasts
·GeographicalTrends
·ForecastsofRecentEntrants-Erbitux
8.PRICINGANDREIMBURSEMENTS
PricingandReimbursementIssues
·PricingandReimbursement
9.STRATEGICRECOMMENDATIONSFORTHEEUROPEANHEADANDNECKCANCERTHERAPEUTICSMARKET
MarketEngineeringRecommendations
·StrategicRecommendations
10.DATABASEOFKEYINDUSTRYPARTICIPANTS
KeyIndustryParticipants
·KeyParticipantsintheHeadandNeckCancerTherapeuticsMarket
11.DECISIONSUPPORTDATABASES
HabitualIndicators
·PrevalenceofSmokers
·PrevalenceofMaleSmokers
·PrevalenceofFemaleSmokers
·AlcoholConsumption
HealthcareExpenditure
·Expenditure
·PharmaceuticalR&DExpenditure
Demography
·FemalePopulationAged65YearsandAbove
·MalePopulationAged65YearsandAbove
·PopulationAged65YearsandAbove
·PercentofPopulationAged65YearsandAbove
This Frost & Sullivan research service titled European Head and Neck Cancer Therapeutics Markets provides market drivers, restraints and revenue forecasts for this market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the chemotherapy and targeted therapies markets.